SE406419B - Sett att framstella ett ympemne vari ingar lipoid a eller alkalibehandlad lipoid a - Google Patents

Sett att framstella ett ympemne vari ingar lipoid a eller alkalibehandlad lipoid a

Info

Publication number
SE406419B
SE406419B SE7214629A SE1462972A SE406419B SE 406419 B SE406419 B SE 406419B SE 7214629 A SE7214629 A SE 7214629A SE 1462972 A SE1462972 A SE 1462972A SE 406419 B SE406419 B SE 406419B
Authority
SE
Sweden
Prior art keywords
lipoid
injective
alkali
treated
manufacturing
Prior art date
Application number
SE7214629A
Other languages
English (en)
Inventor
C Galanos
O Luderitz
O Westphal
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of SE406419B publication Critical patent/SE406419B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7214629A 1971-11-17 1972-11-10 Sett att framstella ett ympemne vari ingar lipoid a eller alkalibehandlad lipoid a SE406419B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (1)

Publication Number Publication Date
SE406419B true SE406419B (sv) 1979-02-12

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7214629A SE406419B (sv) 1971-11-17 1972-11-10 Sett att framstella ett ympemne vari ingar lipoid a eller alkalibehandlad lipoid a

Country Status (10)

Country Link
JP (1) JPS5512002B2 (sv)
AT (1) AT332539B (sv)
BE (1) BE791489A (sv)
CH (1) CH588867A5 (sv)
DD (1) DD102410A5 (sv)
DE (1) DE2157148A1 (sv)
FR (1) FR2160542B1 (sv)
GB (1) GB1416544A (sv)
NL (1) NL7215221A (sv)
SE (1) SE406419B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS581801U (ja) * 1981-06-29 1983-01-07 日興電機工業株式会社 油圧ユニット
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
RU2683027C2 (ru) * 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
FR2160542A1 (sv) 1973-06-29
GB1416544A (en) 1975-12-03
AT332539B (de) 1976-10-11
NL7215221A (sv) 1973-05-21
BE791489A (fr) 1973-05-16
AU4902772A (en) 1974-05-23
FR2160542B1 (sv) 1976-04-23
DE2157148A1 (de) 1973-05-24
DD102410A5 (sv) 1973-12-12
JPS4861621A (sv) 1973-08-29
ATA975872A (de) 1976-01-15
JPS5512002B2 (sv) 1980-03-29
CH588867A5 (sv) 1977-06-15

Similar Documents

Publication Publication Date Title
SE412345B (sv) Foerfarande foer anbringande av vaederbestaendiga tecken eller moenster pa ett foeremal
SE404804B (sv) Sett att framstella 18-metyl-19-nor-20-ketopregnaner
FI65481B (fi) Saett foer gjutning av ett av betong bestaoende roerstycke
SU441704A3 (ru) Способ получения пропионксилидида
FI53696C (fi) Foerfarande foer att bilda ett metalloxidskikt
SE381397B (sv) Forfarande for framstellning av ett aromatiseringsmedel
SE405254B (sv) Sett att framstella 7-hydroxi-ostratriener
SE7309804L (sv) Sett att framstella ett sulfuriserat kalciumalkylfenolat.
SE404528B (sv) Sett att framstella 1alfa-hydroxisteroider
SE406419B (sv) Sett att framstella ett ympemne vari ingar lipoid a eller alkalibehandlad lipoid a
SE7508896L (sv) Forfarande for framstellning av vincamin och andra indolalkaloider.
SE404360B (sv) Sett att framstella 2-nitrobensaldehyd
SE391720B (sv) Sett att framstella bestendiga emulsioner av fornetbara, hogviskosa organopolysiloxaner
SE402458B (sv) Sett att framstella nya 2-amino-6-dialkylamino-dihydropyridiner
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
SE385903B (sv) Sett att framstella 3,16alfa,17xi-trihydroxi-11beta-alkoxi-ostra-1,3,5 (10)- triener
IT956444B (it) Maschera tracheale
SE387944B (sv) Sett att framstella xanton-2-karbonsyraforeningar
SE384197B (sv) Forfarande for tillverkning av ett stoppat foremal
SE388068B (sv) Sett att framstella ett permanentmagnetmaterial pa basis av ferriter av barium och/eller strontium samt ev. av bly
SE383888B (sv) Forfarande for framstellning av alfa-(karbo-(5-indanyloxi))-bensylpenicillin eller ett basiskt salt derav
SE405118B (sv) Sett att framstella 2,4-diamino-5-bensylpyrimidiner
SE394888B (sv) Sett att framstella alfa-amino-2-hydroxifenylettiksyror
SE404192B (sv) Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner
SE382810B (sv) Sett att framstella aminoisokinoliner